Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EMBCNASDAQ:IRMDNASDAQ:SIBNNASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMBCEmbecta$9.64+3.9%$11.04$9.20▼$21.48$563.36M1.13489,555 shs1.09 million shsIRMDiRadimed$60.84+0.2%$55.57$42.34▼$63.29$773.89M0.9243,416 shs188,754 shsSIBNSiBone$18.43+1.9%$17.37$11.70▼$20.05$785.49M0.93390,719 shs1.04 million shsSKINBeauty Health$1.95+0.5%$1.49$0.78▼$2.24$245.68M1.16970,690 shs6.40 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMBCEmbecta0.00%-1.33%-9.23%-24.39%-22.88%IRMDiRadimed0.00%+4.46%+4.72%+15.93%+38.46%SIBNSiBone0.00%+12.45%-2.28%+31.36%+42.54%SKINBeauty Health0.00%+21.12%+18.54%+45.52%+1.56%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEMBCEmbecta4.424 of 5 stars3.21.03.30.01.93.33.8IRMDiRadimed4.6968 of 5 stars2.52.02.54.43.23.31.9SIBNSiBone4.1097 of 5 stars2.55.00.03.32.72.50.6SKINBeauty Health0.3158 of 5 stars0.80.00.00.02.13.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMBCEmbecta 2.33Hold$19.33100.55% UpsideIRMDiRadimed 3.00Buy$72.0018.34% UpsideSIBNSiBone 3.00Buy$22.5022.08% UpsideSKINBeauty Health 1.67Reduce$1.42-27.35% DownsideCurrent Analyst Ratings BreakdownLatest SKIN, SIBN, EMBC, and IRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025EMBCEmbectaBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$25.005/23/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.005/6/2025SIBNSiBoneTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.005/6/2025SIBNSiBoneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.005/6/2025SIBNSiBoneNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $24.005/5/2025SKINBeauty HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.50 ➝ $1.254/10/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$15.004/9/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMBCEmbecta$1.12B0.50$3.34 per share2.89($12.80) per share-0.75IRMDiRadimed$73.24M10.57$1.58 per share38.45$6.85 per share8.88SIBNSiBone$167.18M4.70N/AN/A$3.98 per share4.63SKINBeauty Health$334.30M0.73$0.06 per share30.84$0.41 per share4.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMBCEmbecta$78.30M$0.9010.713.140.614.89%-19.67%12.27%8/8/2025 (Estimated)IRMDiRadimed$19.23M$1.5539.2530.42N/A26.33%23.28%20.59%7/30/2025 (Estimated)SIBNSiBone-$30.91M-$0.64N/AN/AN/A-15.03%-16.00%-11.69%8/4/2025 (Estimated)SKINBeauty Health-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)Latest SKIN, SIBN, EMBC, and IRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q2 2025EMBCEmbecta$0.66$0.70+$0.04$0.40$261.77 million$259.00 million5/8/2025Q1 2025SKINBeauty Health-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million5/5/2025Q1 2025SIBNSiBone-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMBCEmbecta$0.606.22%N/A66.67%N/AIRMDiRadimed$0.681.12%N/A43.87%1 YearsSIBNSiBoneN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ALatest SKIN, SIBN, EMBC, and IRMD DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025EMBCEmbectaquarterly$0.154.51%5/28/20255/28/20256/13/20255/5/2025IRMDiRadimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMBCEmbectaN/A2.481.83IRMDiRadimedN/A8.877.62SIBNSiBone0.218.537.26SKINBeauty Health12.017.476.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMBCEmbecta93.83%IRMDiRadimed92.34%SIBNSiBone98.11%SKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipEMBCEmbecta0.42%IRMDiRadimed36.80%SIBNSiBone3.90%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEMBCEmbecta2,10058.44 million58.20 millionOptionableIRMDiRadimed11012.72 million8.04 millionOptionableSIBNSiBone35042.62 million40.95 millionOptionableSKINBeauty Health1,030125.99 million74.34 millionOptionableSKIN, SIBN, EMBC, and IRMD HeadlinesRecent News About These CompaniesFive new skincare and beauty products we swear by for a healthy glam look!2 hours ago | msn.comThe 10 Best Peptide Serums for Firmer, More Hydrated SkinJune 27 at 11:19 PM | msn.comAre Estrogen Creams The Answer To Age-Related Skin Shifts? Dermatologists Reveal The Truth.June 27 at 1:17 PM | msn.comHere's why neem is great for your skinJune 27 at 1:17 PM | newsbytesapp.comNPlexus Worldwide unveils new Skin Health System line, aims to quintuple skincare revenueJune 27 at 1:17 PM | bizjournals.comAFRICAN SHEA BUTTER IS EVERYTHING | Hair, Skin, and Health benefits!June 27 at 1:17 PM | msn.comElaborate Skin Care Routines Can Cause Teens More Harm Than GoodJune 27 at 1:17 PM | medscape.comMWhat Does Your Skin Really Need? How to Achieve Truly Healthy SkinJune 27 at 2:21 AM | healthline.comHAuthor Carley Fortune’s Self-Care and Beauty SecretsJune 26, 2025 | msn.comWatchdog warning over health risks of skin-lightening beauty trendJune 26, 2025 | msn.comShould I Be Putting Microalgae on My Skin?June 26, 2025 | nymag.comNTower 28 Sale June 2025: Shop Beauty Editor-Tested Skincare And MakeupJune 26, 2025 | msn.comShould I take vitamins or supplements for my skin?June 26, 2025 | aad.orgAThe New Rules of Active Beauty for Summer TravelJune 26, 2025 | latimes.comUrgent health warning issued over skin-lightening beauty drip treatmentsJune 26, 2025 | msn.comLindsay Lohan’s beauty secret for glowing skinJune 25, 2025 | msn.comThis Dermatologist-Recommended SPF Has Major Skin Care Benefits — And It's Almost Half OffJune 25, 2025 | msn.comWith the heat on full swing, local beauty trends are having a fresh-faced momentJune 25, 2025 | thestar.com.myTI’m a beauty reporter and I tried No7’s new Good Intent Skincare Range - out nowJune 25, 2025 | msn.comThe French Skincare Secret: Why Thermal Spring Water Is A Must-Have For Radiant And Healthy SkinJune 25, 2025 | msn.comMillennium Management LLC Raises Stake in The Beauty Health Company (NASDAQ:SKIN)May 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSKIN, SIBN, EMBC, and IRMD Company DescriptionsEmbecta NASDAQ:EMBC$9.64 +0.36 (+3.88%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$9.78 +0.14 (+1.45%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.iRadimed NASDAQ:IRMD$60.84 +0.13 (+0.21%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$61.12 +0.27 (+0.45%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.SiBone NASDAQ:SIBN$18.43 +0.34 (+1.88%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$18.70 +0.27 (+1.47%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Beauty Health NASDAQ:SKIN$1.95 +0.01 (+0.52%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$2.00 +0.05 (+2.36%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
